- Home
- BPMC vs ST Comparison
BPMC vs ST Comparison
Compare BPMC & ST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- ST
- Stock Information
- Founded
- BPMC 2008
- ST 1916
- Country
- BPMC United States
- ST United States
- Employees
- BPMC N/A
- ST N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- ST Industrial Machinery/Components
- Sector
- BPMC Health Care
- ST Industrials
- Exchange
- BPMC Nasdaq
- ST Nasdaq
- Market Cap
- BPMC 5.9B
- ST 5.3B
- IPO Year
- BPMC 2015
- ST 2010
- Fundamental
- Price
- BPMC $90.14
- ST $27.25
- Analyst Decision
- BPMC Buy
- ST Buy
- Analyst Count
- BPMC 20
- ST 13
- Target Price
- BPMC $120.79
- ST $41.00
- AVG Volume (30 Days)
- BPMC 667.8K
- ST 2.1M
- Earning Date
- BPMC 02-13-2025
- ST 02-04-2025
- Dividend Yield
- BPMC N/A
- ST 1.76%
- EPS Growth
- BPMC N/A
- ST N/A
- EPS
- BPMC N/A
- ST N/A
- Revenue
- BPMC $434,415,000.00
- ST $4,017,568,000.00
- Revenue This Year
- BPMC $108.09
- ST N/A
- Revenue Next Year
- BPMC $39.34
- ST N/A
- P/E Ratio
- BPMC N/A
- ST N/A
- Revenue Growth
- BPMC 100.93
- ST N/A
- 52 Week Low
- BPMC $72.24
- ST $27.16
- 52 Week High
- BPMC $121.90
- ST $43.14
- Technical
- Relative Strength Index (RSI)
- BPMC 42.11
- ST 21.16
- Support Level
- BPMC $86.02
- ST $27.16
- Resistance Level
- BPMC $98.41
- ST $31.01
- Average True Range (ATR)
- BPMC 3.28
- ST 0.93
- MACD
- BPMC -0.76
- ST -0.33
- Stochastic Oscillator
- BPMC 33.04
- ST 1.67
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About ST Sensata Technologies Holding plc
Sensata Technologies is a global supplier of sensors for transportation and industrial applications. Sensata sells a bevy of pressure, temperature, force, and position sensors into the automotive, heavy vehicle, industrial, heating, ventilation, and cooling, and aerospace markets. The majority of the firm's revenue comes from the automotive market, where it focuses on bumper-in applications.